BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1697411)

  • 1. Modulation of a constitutive transcriptional block at exon-1 controls human c-myc oncogene expression.
    Re GG; Antoun GR; Zipf TF
    Oncogene; 1990 Aug; 5(8):1247-50. PubMed ID: 1697411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation.
    Eick D; Polack A; Kofler E; Bornkamm GW
    Oncogene; 1988 Oct; 3(4):397-403. PubMed ID: 3078949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DMSO induced modulation of c-myc steady-state RNA levels in a variety of different cell lines.
    Darling D; Tavassoli M; Linskens MH; Farzaneh F
    Oncogene; 1989 Feb; 4(2):175-9. PubMed ID: 2648255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple mechanisms of regulation of the human c-myb gene during myelomonocytic differentiation.
    Boise LH; Gorse KM; Westin EH
    Oncogene; 1992 Sep; 7(9):1817-25. PubMed ID: 1323820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional down-regulation of c-myc expression by protein synthesis-dependent and -independent pathways in a human T lymphoblastic tumor cell line.
    Bading H; Moelling K
    Cell Growth Differ; 1990 Mar; 1(3):113-7. PubMed ID: 2127692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
    St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
    Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of phorbol ester-induced down-regulation of myc protein in the phorbol ester-tolerant mutant of HL-60 promyelocytes.
    Gailani D; Cadwell FJ; O'Donnell PS; Hromas RA; Macfarlane DE
    Cancer Res; 1989 Oct; 49(19):5329-33. PubMed ID: 2670202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered myc gene transcription and intron-induced stabilization of myc RNAs in two mouse plasmacytomas.
    Bauer SR; Piechaczyk M; Nordan RP; Owens JD; Nepveu A; Marcu KB; Mushinski JF
    Oncogene; 1989 May; 4(5):615-23. PubMed ID: 2657576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative modes of c-myc regulation in growth factor-stimulated and differentiating cells.
    Nepveu A; Levine RA; Campisi J; Greenberg ME; Ziff EB; Marcu KB
    Oncogene; 1987; 1(3):243-50. PubMed ID: 2455262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-myc and c-fos gene regulation during mouse liver regeneration.
    Sobczak J; Mechti N; Tournier MF; Blanchard JM; Duguet M
    Oncogene; 1989 Dec; 4(12):1503-8. PubMed ID: 2512526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of c-myc gene regulation in folic acid-induced kidney regeneration.
    Asselin C; Marcu KB
    Oncogene Res; 1989; 5(1):67-72. PubMed ID: 2476708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
    Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A
    Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
    Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
    Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple calcium-mediated mechanisms regulate c-myc expression in HL-60 cells.
    Salehi Z; Niedel JE
    J Immunol; 1990 Jul; 145(1):276-82. PubMed ID: 2113555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of a c-myc mRNA initiated in intron 1 with the normal c-myc mRNA and similar regulation of both transcripts in mammalian cells.
    Ray D; Robert-Lézénès J
    Oncogene Res; 1989; 5(1):73-8. PubMed ID: 2674860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered regulation of c-myc in an HL-60 differentiation resistant subclone, HL-60-1E3.
    Ely CM; Leftwich JA; Chenevix-Trench G; Hall RE; Westin EH
    Cancer Res; 1987 Sep; 47(17):4595-600. PubMed ID: 3476196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct mechanisms of c-myc and lymphokine gene expression in an antigen specific T cell clone.
    Heckford SE; Gelmann EP; Matis LA
    Oncogene; 1988 Oct; 3(4):415-21. PubMed ID: 3152599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
    Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT
    Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.